Cargando…
Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria
BACKGROUND: There appears to exist a potentially important interplay between diabetes mellitus (DM) and Helicobacter pylori (H. pylori) infection. Findings from previous studies have been conflicting. Only a few studies have examined the topic in a sub-Saharan African population. This study sought t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433385/ https://www.ncbi.nlm.nih.gov/pubmed/22686510 http://dx.doi.org/10.1186/1756-0500-5-284 |
_version_ | 1782242311510425600 |
---|---|
author | Oluyemi, Aderemi Anomneze, Ebere Smith, Stella Fasanmade, Olufemi |
author_facet | Oluyemi, Aderemi Anomneze, Ebere Smith, Stella Fasanmade, Olufemi |
author_sort | Oluyemi, Aderemi |
collection | PubMed |
description | BACKGROUND: There appears to exist a potentially important interplay between diabetes mellitus (DM) and Helicobacter pylori (H. pylori) infection. Findings from previous studies have been conflicting. Only a few studies have examined the topic in a sub-Saharan African population. This study sought to determine the prevalence of H. pylori infection among Type 2 diabetes mellitus (T2DM) patients in Lagos, Nigeria. FINDINGS: H. pylori infection was detected in 18% of T2DM patients and 13% of controls but there was no statistical significance in this difference (p = 0.52). The prevalence of H. pylori was neither associated with the known duration of T2DM nor was it associated with age, gender, body mass index (BMI), smoking status. T2DM was not shown to be a risk factor independently associated with risk for H. pylori infection (OR = 0.87, 95% CI = 0.58-1.31, p = 0.57). CONCLUSIONS: The lack of a statistical significant difference between the H. pylori infection rates in T2DM patients and controls suggests that the infection is not increased in T2DM. Larger studies need to be conducted to confirm the study findings. |
format | Online Article Text |
id | pubmed-3433385 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34333852012-09-05 Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria Oluyemi, Aderemi Anomneze, Ebere Smith, Stella Fasanmade, Olufemi BMC Res Notes Short Report BACKGROUND: There appears to exist a potentially important interplay between diabetes mellitus (DM) and Helicobacter pylori (H. pylori) infection. Findings from previous studies have been conflicting. Only a few studies have examined the topic in a sub-Saharan African population. This study sought to determine the prevalence of H. pylori infection among Type 2 diabetes mellitus (T2DM) patients in Lagos, Nigeria. FINDINGS: H. pylori infection was detected in 18% of T2DM patients and 13% of controls but there was no statistical significance in this difference (p = 0.52). The prevalence of H. pylori was neither associated with the known duration of T2DM nor was it associated with age, gender, body mass index (BMI), smoking status. T2DM was not shown to be a risk factor independently associated with risk for H. pylori infection (OR = 0.87, 95% CI = 0.58-1.31, p = 0.57). CONCLUSIONS: The lack of a statistical significant difference between the H. pylori infection rates in T2DM patients and controls suggests that the infection is not increased in T2DM. Larger studies need to be conducted to confirm the study findings. BioMed Central 2012-06-11 /pmc/articles/PMC3433385/ /pubmed/22686510 http://dx.doi.org/10.1186/1756-0500-5-284 Text en Copyright ©2012 Oluyemi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Oluyemi, Aderemi Anomneze, Ebere Smith, Stella Fasanmade, Olufemi Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria |
title | Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria |
title_full | Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria |
title_fullStr | Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria |
title_full_unstemmed | Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria |
title_short | Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria |
title_sort | prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in lagos, nigeria |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433385/ https://www.ncbi.nlm.nih.gov/pubmed/22686510 http://dx.doi.org/10.1186/1756-0500-5-284 |
work_keys_str_mv | AT oluyemiaderemi prevalenceofamarkerofactivehelicobacterpyloriinfectionamongpatientswithtype2diabetesmellitusinlagosnigeria AT anomnezeebere prevalenceofamarkerofactivehelicobacterpyloriinfectionamongpatientswithtype2diabetesmellitusinlagosnigeria AT smithstella prevalenceofamarkerofactivehelicobacterpyloriinfectionamongpatientswithtype2diabetesmellitusinlagosnigeria AT fasanmadeolufemi prevalenceofamarkerofactivehelicobacterpyloriinfectionamongpatientswithtype2diabetesmellitusinlagosnigeria |